CN102925505A - Method for preparing highly-purified L-Lysine sulphate through one-time fermentation - Google Patents
Method for preparing highly-purified L-Lysine sulphate through one-time fermentation Download PDFInfo
- Publication number
- CN102925505A CN102925505A CN2012104400822A CN201210440082A CN102925505A CN 102925505 A CN102925505 A CN 102925505A CN 2012104400822 A CN2012104400822 A CN 2012104400822A CN 201210440082 A CN201210440082 A CN 201210440082A CN 102925505 A CN102925505 A CN 102925505A
- Authority
- CN
- China
- Prior art keywords
- parts
- product
- lysine
- acid
- filter membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 32
- VJDRZAPMMKFJEA-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;sulfuric acid Chemical compound OS(O)(=O)=O.NCCCC[C@H](N)C(O)=O VJDRZAPMMKFJEA-JEDNCBNOSA-N 0.000 title claims abstract description 17
- 238000000855 fermentation Methods 0.000 title claims description 21
- 230000004151 fermentation Effects 0.000 title claims description 21
- 239000004472 Lysine Substances 0.000 claims abstract description 40
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 38
- 235000018977 lysine Nutrition 0.000 claims abstract description 38
- 241000894006 Bacteria Species 0.000 claims abstract description 22
- 239000000047 product Substances 0.000 claims description 67
- 150000001413 amino acids Chemical group 0.000 claims description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 229930182817 methionine Natural products 0.000 claims description 27
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 25
- 229940024606 amino acid Drugs 0.000 claims description 23
- 235000001014 amino acid Nutrition 0.000 claims description 23
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 22
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 claims description 20
- 239000012528 membrane Substances 0.000 claims description 20
- 238000002360 preparation method Methods 0.000 claims description 17
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 16
- 229960002989 glutamic acid Drugs 0.000 claims description 13
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 12
- 235000003704 aspartic acid Nutrition 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 11
- 239000000654 additive Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 108091033319 polynucleotide Proteins 0.000 claims description 10
- 102000040430 polynucleotide Human genes 0.000 claims description 10
- 239000002157 polynucleotide Substances 0.000 claims description 10
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 7
- 230000000968 intestinal effect Effects 0.000 claims description 7
- 239000004475 Arginine Substances 0.000 claims description 6
- 239000004471 Glycine Substances 0.000 claims description 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 6
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 6
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 6
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 6
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 6
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 6
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 6
- 239000004473 Threonine Substances 0.000 claims description 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 6
- 150000001510 aspartic acids Chemical class 0.000 claims description 6
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 6
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 6
- 230000008676 import Effects 0.000 claims description 6
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 6
- 229960000310 isoleucine Drugs 0.000 claims description 6
- 235000005772 leucine Nutrition 0.000 claims description 6
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 6
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 150000002614 leucines Chemical class 0.000 claims description 4
- 238000009630 liquid culture Methods 0.000 claims description 4
- 125000000539 amino acid group Chemical group 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000000586 desensitisation Methods 0.000 claims description 3
- 230000005764 inhibitory process Effects 0.000 claims description 3
- 238000004321 preservation Methods 0.000 abstract description 12
- 230000004060 metabolic process Effects 0.000 abstract description 9
- 108090000623 proteins and genes Proteins 0.000 abstract description 7
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 abstract 1
- 229960003646 lysine Drugs 0.000 description 34
- 239000012535 impurity Substances 0.000 description 13
- 239000000203 mixture Substances 0.000 description 8
- 108010045235 heat-shock sigma factor 32 Proteins 0.000 description 7
- 230000002035 prolonged effect Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 150000007523 nucleic acids Chemical group 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 150000005838 radical anions Chemical class 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- 239000006200 vaporizer Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000012262 fermentative production Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000004459 forage Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 108091000044 4-hydroxy-tetrahydrodipicolinate synthase Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000186031 Corynebacteriaceae Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229960005337 lysine hydrochloride Drugs 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Abstract
The invention provides a method for preparing products containing L-Lysine sulphate by fermenting, wherein a gene which is known to have nothing to do with lysine metabolism is lead into bacteria which produce L-Lysine, and the content of lysine in the L-Lysine sulphate achieves purity of market products. Furthermore, the invention further provides the L-Lysine sulphate produced by the method, and the L-Lysine sulphate can obviously increase moisture absorption resistance ability relative to existing products containing the L-Lysine sulphate, thereby being suitable for long-term preservation.
Description
Technical field
The invention belongs to the amino acid fermentation field, particularly, the preparation that the present invention relates to ferment contains the method for the product of L-lysine sulfate, it comprises that innovation ground imports one to the bacterium that produces 1B and usually is considered to the gene irrelevant with the Methionin metabolism, and lysine content has reached the purity of commercially available prod in the product.In addition, the present invention also provides product that described method produces and application etc.
Background technology
1B is important amino acid starting material, can be used as seasonings, food, fodder additives use, also can be used as the effective or adjunct ingredient in healthcare products, the medicine, be widely used in grocery trade, feed industry, pharmacy industry and other chemical industry, especially contain impurity lysine salt (as, vitriol, hydrochloride), generally also can directly use as fodder additives.Current, the production of 1B mainly is by the fermentative production of microorganism, as utilizing coryneform bacteria production.
In the various product of lysine salt, especially lysine sulfate, have very large shortcoming, namely have larger water absorbability, thus so that water content wherein too high (as, greater than 3%), too high like this product humidity easily causes product caking, is difficult for preserving, and is especially easily mouldy during prolonged preservation, even this does not allow when using as the lower feed of safety requirements yet.Especially the inventor finds, China's wide farmers, penkeeping is small, lysine salt is little as the fodder additives consumption, therefore whole bag is bought the lysine salt product of (often unit price is more cheap), therefore have more retention, the water absorbability of product is larger on their impact during prolonged preservation.
For this reason, Japan aginomoto company adopts the equivalent of regulating acid radical anion and Methionin recently to overcome this defective, the equivalence ratio of acid radical anion and Methionin is adjusted between 0.68～0.95, be the equivalent of acid radical anion less than the equivalent of Methionin, can reduce to a certain extent like this equilibrium moisture (referring to No. the 03120099th, Chinese patent) of product.Aforesaid method can bring better resistance to water soak for lysine hydrochloride, is under 33～58% the routine preservation environment in relative humidity, substantially can so that the equilibrium moisture of product be controlled at below 3%; Yet, for lysine sulfate, to preserve under the environment at this, equilibrium moisture substantially all can surpass 3%, even can surpass 5%.
Study for a long period of time and test through the inventor, found unexpectedly, in the poor lysine sulfate of resistance to water soak, add the amino acid of a certain proportion of other type, although can reduce the purity of lysine sulfate in the product, but meeting is so that the resistance to water soak of lysine sulfate product is significantly improved, and the product of this purity does not affect it as the effectiveness of lysine additives for forage.
And, the inventor has also worked out a kind of new fermentation process, the thinking of pathways metabolism that generates Methionin with the continuous reinforcement of prior art is opposite, open other bypasses of non-Methionin metabolism, especially in very complicated metabolic pathway, searched out unexpectedly a kind of enzyme, the degree of opening is very moderate, thereby can disposable fermentation obtain Methionin and other type amino acid ligand than suitable product, need not too much step of preparation process, the product that obtains still can be as lysine additives for forage, and resistance to water soak is significantly improved.
Further, the inventor finds, after having added the sulfuric acid salify, lysine content in the resulting product of this disposable fermentation is difficult to go beyond 55%, and in the market in the product sold take the high density product as main (general lysine content as 55% or more than), therefore lysine content in the product is risen at least 55%, could be than being easier to carry out marketing.For this reason, the inventor also provides the method for the easy fermentative production high purity lysine sulfate of a kind of step.
Summary of the invention
The technical problem to be solved in the present invention is that the fermentation preparation that provides new contains the method for the product of L-lysine sulfate, and it comprises that innovation ground imports one to the bacterium that produces 1B and usually is considered to the gene irrelevant with the Methionin metabolism.In addition, the present invention also provides product that the method produces and application etc.
Particularly, in first aspect, the invention provides the method that the fermentation preparation contains the product of L-lysine sulfate, it comprises:
(1) albumen or the polynucleotide of its variant of encoding amino acid sequence shown in SEQ ID No:1 is imported the bacterium that produces 1B;
(2) bacterium of under fermentation conditions liquid culture step (1) acquisition is collected the supernatant liquor of cultivating, and allows this supernatant liquor by filter membrane, keeps filtrate, comprises the amino acid of following weight proportion in the described filtrate:
54～60 parts of Methionins are preferably 55～57 parts, more preferably 55.7 parts;
1.3～1.9 parts of aspartic acids are preferably 1.5～1.65 parts, more preferably 1.61 parts;
0.8～1.2 part of Threonine is preferably 0.9～1.1 part, more preferably 1 part;
0.45～0.7 part of Serine is preferably 0.55～0.65 part, more preferably 0.6 part;
2～3 parts in L-glutamic acid is preferably 2.3～2.8 parts, more preferably 2.56 parts;
0.8～1.1 part of glycine is preferably 0.85～1.05 part, more preferably 0.96 part;
1.3～1.7 parts of L-Ala are preferably 1.4～1.6 parts, more preferably 1.5 parts;
0.8～1.2 part of α-amino-isovaleric acid is preferably 0.9～1.1 part, more preferably 0.99 part;
0.35～0.55 part of methionine(Met) is preferably 0.4～0.5 part, more preferably 0.44 part;
0.5～0.8 part of Isoleucine is preferably 0.6～0.7 part, more preferably 0.63 part;
1.1～1.6 parts of leucines are preferably 1.25～1.45 parts, more preferably 1.36 parts;
0.55～0.9 part in tyrosine is preferably 0.65～0.8 part, more preferably 0.72 part;
0.5～0.85 part of phenylalanine is preferably 0.6～0.75 part, more preferably 0.67 part;
0.8～1.2 part of Histidine is preferably 0.9～1.1 part, more preferably 1.02 parts; With,
Arginine, is preferably 1.1～1.3 parts, more preferably 1.18 parts by 1～1.5 part;
(3) filtrate that obtains to step (2), add sulfuric acid and concentrate drying to water ratio less than 3% (w/w).
In the specific embodiment of the present invention, the albumen of described polynucleotide encoding aminoacid sequence shown in SEQ ID No:1.The thinking of pathways metabolism that generates Methionin with the continuous reinforcement of prior art is opposite, the method of first aspect present invention is opened other bypasses of non-Methionin metabolism moderately by introducing the RNA polymerase sigma-32 factor, thereby can disposable fermentation obtain Methionin and other type amino acid ligand than suitable product, need not too much step of preparation process.The RNA polymerase sigma-32 factor is by working to the heat-shocked promotor specifically, and participates in the heat-shocked process, affect transcribing of heat-shocked associated protein, thereby the poisonous substance that the microorganism in the glutamic acid fermentation overcomes the metabolism generation is exerted an influence.(can be referring to NCBI (http://www.ncbi.nlm.nih.gov) albumen and gene accession number AAB18436.1 although the RNA polymerase sigma-32 factor is disclosed; Also can be referring to No. the 96193336th, Chinese patent application), but RNA polymerase sigma-32 produces the impact that distributes but without any enlightenment on fermenting lysine and on wherein amino acid.Therefore, preferably in the method for first aspect present invention, the aminoacid sequence that the aminoacid sequence of described variant obtains for the aminoacid sequence shown in SEQ ID No:1 being added, lack or replaces and several amino-acid residue.
More preferably in the method for first aspect present invention, the aminoacid sequence of described variant is for adding, lack the aminoacid sequence shown in SEQ IDNo:1 or replacing the aminoacid sequence that and several amino-acid residue obtain, and the polynucleotide of this variant of encoding import to produce behind the bacterium of 1B under fermentation conditions liquid culture, and the supernatant liquor of cultivation comprises the amino acid of weight proportion described in first aspect present invention.
Those skilled in the art can derive according to the aminoacid sequence of the RNA polymerase sigma-32 factor nucleotide sequence of its coding, the nucleotide sequence of codon modify preferably, the degree of opening to regulate this pathways metabolism.In the specific embodiment of the present invention, the nucleotide sequence of described polynucleotide is shown in SEQ ID NO:2.
Described polynucleotide can be imported into the bacterium that produces 1B by various modes well-known to those skilled in the art, as long as can make the bacterium that produces 1B express the described RNA polymerase sigma-32 factor.Described polynucleotide can directly be imported into, such as utilizing the transfered cells such as microsome, particle gun; Also can indirectly be imported into, such as can be by being structured in transfered cell on the carriers such as plasmid.The described polynucleotide that import can be incorporated on the genome of cell and express, and expression also can dissociate.In the method for preferred first aspect present invention, engineering bacteria is intestinal bacteria, being more preferably the intestinal bacteria to 1B feedback inhibition desensitization, most preferably is to express intestinal bacteria to the dihydrodipicolinic acid synthase of 1B feedback inhibition desensitization (referring to No. the 94194962nd, Chinese patent).Because intestinal bacteria itself are suitable as the cloning host bacterium, therefore preferred described polynucleotide are to import colibacillary by calcium chloride transformation.
In this article, expression used " part " during proportioning, be in order to be illustrated in the described composition, the weight proportion of each composition, this can understand to those skilled in the art.Weight " part " can be regarded as the ratio of these compositions in said composition when more than one composition limits in to composition.
In this article, inoculum size have those skilled in the art can the conventional implication of understanding, specifically when representing with volume percent, refer to bacterial culture fluid (the bacterium liquid of access) volume with respect to the percentage of the culture volume that is access in.
Use filter membrane can remove impurity, high molecular impurity especially, enrichment Methionin, thus improve Methionin purity.Filter membrane can be ultra-filtration membrane, also can be nanofiltration membrane, preferably ultra-filtration membrane.The inventor finds, uses molecular weight cut-off to be the filter membrane of 1000Da, can disposable lysine content in the finished product be brought up to more than 55%, reaches the needs that are fit to marketing, and simple operating steps.Therefore, in the method for preferred first aspect present invention, filter membrane is that molecular weight cut-off is the filter membrane of 500～5000Da, and preferably molecular weight cut-off is the filter membrane of 800～3000Da, being more preferably the filter membrane that molecular weight cut-off is 900～2000Da, most preferably is that molecular weight cut-off is the filter membrane of 1000Da.
Add sulfuric acid in the method for first aspect present invention, thus can with this basic aminoacids salify of Methionin, be easier in drying process, condense into particle.The ratio of Methionin can be constant in the add-on of sulfuric acid and the supernatant liquor.Preferably in the method for first aspect present invention, the mol ratio of Methionin and sulfuric acid is 1～3: 0.5～1.5, more preferably 1.5～2.5: 0.75～1.25, most preferably be 2: 1.
Liquid concentrated and dry can be by this area equipment commonly used, as, vaporizer, drying machine and/or baking oven carry out.Preferably in the method for first aspect present invention, supernatant liquor is concentrated through vaporizer successively, sprays into granulation in the fluid bed dryer, and in oven drying.
In second aspect, the invention provides the product (it is fodder additives preferably) that contains L-lysine sulfate, wherein lysine content is greater than 54% (w/w), be preferably greater than 55% (w/w), also preferred content is 54～60% (w/w), more preferably 55～57% (w/w) most preferably are 55.7% (w/w).Such lysine content is convenient to marketing.
The product of preferred second aspect present invention comprises 72.1～80.1 parts of lysine sulfate, is preferably 73.5～76.1 parts, more preferably 74.4 parts; 1.3～1.9 parts of aspartic acids are preferably 1.5～1.65 parts, more preferably 1.61 parts; With, 2～3 parts in L-glutamic acid is preferably 2.3～2.8 parts, more preferably 2.56 parts.
More preferably the product of second aspect present invention comprises the amino acid of following weight proportion:
72.1～80.1 parts of lysine sulfate are preferably 73.5～76.1 parts, more preferably 74.4 parts;
1.3～1.9 parts of aspartic acids are preferably 1.5～1.65 parts, more preferably 1.61 parts;
0.8～1.2 part of Threonine is preferably 0.9～1.1 part, more preferably 1 part;
0.45～0.7 part of Serine is preferably 0.55～0.65 part, more preferably 0.6 part;
2～3 parts in L-glutamic acid is preferably 2.3～2.8 parts, more preferably 2.56 parts;
0.8～1.1 part of glycine is preferably 0.85～1.05 part, more preferably 0.96 part;
1.3～1.7 parts of L-Ala are preferably 1.4～1.6 parts, more preferably 1.5 parts;
0.8～1.2 part of α-amino-isovaleric acid is preferably 0.9～1.1 part, more preferably 0.99 part;
0.35～0.55 part of methionine(Met) is preferably 0.4～0.5 part, more preferably 0.44 part;
0.5～0.8 part of Isoleucine is preferably 0.6～0.7 part, more preferably 0.63 part;
1.1～1.6 parts of leucines are preferably 1.25～1.45 parts, more preferably 1.36 parts;
0.55～0.9 part in tyrosine is preferably 0.65～0.8 part, more preferably 0.72 part;
0.5～0.85 part of phenylalanine is preferably 0.6～0.75 part, more preferably 0.67 part;
0.8～1.2 part of Histidine is preferably 0.9～1.1 part, more preferably 1.02 parts; With,
Arginine, is preferably 1.1～1.3 parts, more preferably 1.18 parts by 1～1.5 part.
Confirm through animal, even further comprise fermentation impurity, to raise middle use still be safe to the product of second aspect present invention animal is fed, and more because the amino acid whose adding of other kinds, can also improve to a certain extent the effect of fodder additives.Therefore, the product of preferred second aspect present invention is fodder additives.
Study for a long period of time and test through the inventor, found unexpectedly, add the amino acid of a certain proportion of other type in the poor lysine sulfate of resistance to water soak, meeting is so that the resistance to water soak of lysine sulfate product is significantly improved therefore suitable prolonged preservation.In this article, equilibrium moisture content can with the equilibrium moisture Alternate, be the water absorbability index that those skilled in the art commonly use, refer under certain relative humidity environment, water ratio when the product water ratio reaches balance (that is, water ratio neither can increase, and also can not reduce).Preferably can be under the routine preservation condition (relative humidity is 33～58%) prolonged preservation, (balance) water ratio of the product of second aspect present invention is less than 5% (w/w), preferably less than 3% (w/w), be more preferably less than 2.5% (w/w).
The product of second aspect present invention can not contain other impurity (that is, the product of second aspect present invention is comprised of above-mentioned amino acid), also can further comprise impurity, such as fermentation impurity.Through inventor's research, other impurity in the product of the method preparation of employing first aspect present invention can not make amino acid product water ratio under the routine preservation condition of aforementioned proportion be higher than 3% (w/w).Therefore the product of preferred second aspect present invention is by the method preparation of first aspect present invention.
In the third aspect, the invention provides lysine sulfate, aspartic acid and L-glutamic acid unite the preparation second aspect present invention product in application, preferably provide lysine sulfate, aspartic acid, Threonine, Serine, L-glutamic acid, glycine, L-Ala, α-amino-isovaleric acid, methionine(Met), Isoleucine, leucine, tyrosine, phenylalanine, Histidine and arginine unite the preparation second aspect present invention product in application.Wherein, this product water ratio is little, and preferred (balance) water ratio is more preferably less than 3% (w/w), most preferably less than 2.5% (w/w) less than 5% (w/w).
The present invention has following beneficial effect: product resistance to water soak of the present invention is good, so that the water ratio in the product reduces more than 50%, is suitable in the southern and northern wide geographic area standing storage of China, transportation and use; Product of the present invention is as the 1B feed, and is safe and reliable, and effect promotes to some extent; The lysine content of product of the present invention has existing commercially available Methionin nicotinate product corresponding, and institute is so that business promotion; Fermentation process implementation step of the present invention is simple, only needs one time fermentation, has saved production cost, without potential safety hazard; The purification step of fermentation process of the present invention has made things convenient for operation, has also saved production cost.
For the ease of understanding, below will describe in detail the present invention by specific embodiment.It needs to be noted, these descriptions only are exemplary descriptions, do not consist of limitation of the scope of the invention.According to the discussion of this specification sheets, many variations of the present invention, change all are apparent concerning one of ordinary skill in the art.
In addition, the present invention has quoted open source literature, and these documents are in order more clearly to describe the present invention, and their full text content is all included this paper in and carried out reference, just looks like that repeated description is excessively the same in this article for their full text.
Embodiment
Further specify by the following examples content of the present invention.As do not specialize, the conventional means that used technique means is well known to those skilled in the art among the embodiment and commercially available common instrument, reagent can be referring to the references such as manufacturers instruction of " molecular cloning experiment guide (the 3rd edition) " (Science Press), " Microbiology Experiment (the 4th edition) " (Higher Education Publishing House) and corresponding instrument and reagent.
The preparation of embodiment 1RNA polysaccharase sigma-32 factor gene construct
Aminoacid sequence according to the albumen accession number AAB18436.1 of NCBI (http://www.ncbi.nlm.nih.gov), the inventor has designed appropriate expression type codon (non-expression amount optimizing codon), and entrust Shanghai to give birth to the gene of the worker composite coding RNA polymerase sigma-32 of the Bioisystech Co., Ltd factor and be built among the colibacillus expression plasmid pET-20b (+) (can available from U.S. Novagen company, goods number Cat.No.69739-3) by commercial sources.Clone's process is carried out with reference to the operational guidance of " molecular cloning experiment guide " and used commercialization reagent, and concise and to the point process is as follows:
Pass through automatic dna synthesizer, the nucleic acid fragment of synthetic RNA polymerase sigma-32 factor gene, with T4 polynucleotide kinase (available from TaKaRa company) 5 ' end of these nucleic acid fragments is carried out phosphorylation, then equimolar ratio is mixed behind these 5 nucleic acid fragments in 65 ℃ of sex change 5 minutes, annealing is cooled to 16 ℃, adds T4DNA ligase enzyme (available from TaKaRa company) and connects 12 hours.Then, get the above-mentioned connection product of 1 μ L and in 50 μ L reaction volumes, carry out pcr amplification, wherein forward primer (has been introduced the EcoRI restriction enzyme site) shown in the SEQ ID No:3 of sequence table, reverse primer (introduced Xho I restriction enzyme site) shown in the SEQ ID No:4 of sequence table, reaction conditions was: with 94 ℃ of sex change 4 minutes, then extend with 94 ℃ of sex change 30 seconds, 63 ℃ of annealing 60 seconds and 72 ℃ and carried out 35 circulations in 35 seconds, extended 4 minutes with 72 ℃ at last and be cooled to 4 ℃.
The above-mentioned PCR product of agarose gel electrophoresis, reclaim the approximately fragment of 900bp size, with EcoR I and this fragment of XhoI double digestion, and be connected with the T4DNA ligase enzyme through the pET-20b of these two endonuclease digestions (+) plasmid, be transformed among the intestinal bacteria Top10F '.Choose positive colony, extract plasmid wherein, through sequence verification, the corresponding nucleotide sequence is shown in the SEQ ID No:2 of inventor's design, encoded the RNA polymerase sigma-32 factor shown in SEQ IDNo:1 is returned the plasmid (called after pET-sigma) that builds by company.
The preparation of the L-lysine sulfate product of embodiment 2 Escherichia coli fermentations
The coli strain W3110 (tyrA) of the product 1B that the described method of No. the 94194962nd, Chinese patent is made up/pCABD2, transform the pET-sigma plasmid, through identifying that obtaining to transform positive colony (behind the called after W3110 (tyrA)/pCABD2-sigma), carries out the fermenting lysine experiment for No. 03120099 with reference to Chinese patent respectively with bacterial strain W3110 (tyrA)/pCABD2 and W3110 (tyrA)/pCABD2-sigma.In brief, bacterial strain is accessed in the liquid LB substratum shaking culture reach 0.35 to OD500, (every liter of culture medium prescription is 100g glucose, 60g (NH to the inoculum size access fermenting lysine substratum take 5%
4)
2SO
4, 50g CaCO
3, 35mL peptone-B (Soy Protein Enzymatic Hydrolysate, available from the true Bioisystech Co., Ltd in Shanghai, total nitrogen content is not less than 3%), 1g KH
2PO
4, 400mgMgSO
47H
2O, 200mg METHIONINE, 10mg FeSO
47H
2O, 8.1mg MnSO
44H
2O, 300 μ g vitamin Hs and 200 μ g VITMAIN B1 are adjusted to pH7 with Tris-HCl) in cultivated 72 hours with 36 ℃ of vibrations (250rpm).Then, centrifugal collection medium supernatant (fermented liquid).Then with supernatant liquor respectively the ultra-filtration membrane by molecular weight cut-off 1000Da (can be available from German Sartorius AG, goods number: 3051460901E-SG), with the 1B content in the quantitative filtrate of HPLC and other compositions.The result is as shown in table 1, filtrate with respect to W3110 (tyrA)/pCABD2, the lysine content of W3110 (tyrA)/pCABD2-sigma slightly descends, but other amino acid whose kinds and ratio obviously improve, other impurity (mainly are the impurity (inorganic salt) that is lower than the amino acid molecular amount, and be higher than the impurity (sugar of amino acid molecular amount, polysaccharide, peptide and albumen) estimate most ofly to be removed by membrane retention) content substantially constant, if therefore the character of both tunnings has difference, estimation is owing to other amino acid whose kind and ratio.
Comparison of ingredients in table 1 filtrate
Add the vitriol oil to the above-mentioned filtrate that is obtained by different strains respectively so that the mol ratio of the Methionin in sulfuric acid and the supernatant liquor is 1: 2, then place concentrate on the vaporizer after, spray into granulation in the fluid bed dryer with vaporific.Particle is placed the baking oven inner drying, until water ratio is no more than 1%, obtain the L-lysine sulfate product.
The resistance to water soak test of embodiment 3L-lysine product
Get embodiment 2 by the L-lysine sulfate product (being designated as sigma) of W3110 (tyrA)/pCABD2-sigma preparation with by the L-lysine sulfate product (being designated as contrast 1) of W3110 (tyrA)/pCABD2 preparation.
In addition, the chemically pure reagent of getting following weight proportion mixes (being designated as contrast 2): lysine sulfate, 69.9; Aspartic acid 1.54; Threonine, 0.94; Serine, 0.56; L-glutamic acid, 2.4; Glycine, 0.92; L-Ala, 1.4; α-amino-isovaleric acid, 0.93; Methionine(Met), 0.42; Isoleucine, 0.61; Leucine, 1.27; Tyrosine, 0.67; Phenylalanine, 0.64; Histidine, 0.97; With, arginine, 1.1.
In addition, the chemically pure reagent of getting following weight proportion mixes (being designated as contrast 3): lysine sulfate, 69.9; Aspartic acid 1.54; With, L-glutamic acid, 2.4.
Above-mentioned sample was being placed 7 days under with the environment of different relative humidity under 25 ℃ respectively, then measure the equilibrium moisture content in the product at that time, the result is as shown in table 2, improve the easy moisture absorption of lysine sulfate product of production based on prior art, (relative humidity 33～58%) is difficult to control water ratio below 3% and prolonged preservation under the routine preservation environment, if and mix with other amino acid of some particular types and ratio, then can significantly strengthen its resistance to water soak, make it prolonged preservation, wherein aspartic acid and L-glutamic acid are larger to the resistance to water soak gain effects of lysine sulfate, but can not strengthen its resistance to water soak fully; Impurity in the tunning can reduce the resistance to water soak of lysine sulfate to a certain extent, as long as still can keep wherein having other amino acid of some particular types and ratio, just can offset the disadvantageous effect that impurity produces, and make it prolonged preservation.
The equilibrium moisture content test result of table 2 variant production
| Sample | Contrast 1 | Contrast 2 | Contrast 3 | sigma |
| Relative humidity 33% | 3.94％ | 1.01％ | 0.78％ | 1.61％ |
| Relative humidity 43% | 5.25％ | 2.43％ | 1.35％ | 2.18％ |
| Relative humidity 58% | 7.43％ | 3.74％ | 1.62％ | 2.79％ |
Embodiment 4L-lysine sulfate product is to the effectiveness of calf growth effect
Entrust academy of agricultural sciences, Ningxia herding institute to compare test with L-lysine sulfate product and the commercially available 85%L-lysine hydrochloride fodder additives by W3110 (tyrA)/pCABD2-sigma preparation of embodiment 2, feed the calf of raising for 4～6 ages in week Deng addition (in 1B wherein), take the feed that do not add Methionin as contrast, the product of embodiment 2 on average makes calf adding weight (ADG) improve 17.0%, and commercially available product on average improves 15.8%, wherein slightly is better than the commercially available prod and may gives the credit to the amino acid that also contains more other kinds in the product of embodiment 2; Duration of test does not have the untoward reaction report.
Claims (10)
1. the fermentation preparation contains the method for the product of L-lysine sulfate, and it comprises:
(1) albumen or the polynucleotide of its variant of encoding amino acid sequence shown in SEQ ID No:1 is imported the bacterium that produces 1B;
(2) bacterium of under fermentation conditions liquid culture step (1) acquisition is collected the supernatant liquor of cultivating, and allows this supernatant liquor by filter membrane, keeps filtrate, comprises the amino acid of following weight proportion in the described filtrate:
54～60 parts of Methionins are preferably 55～57 parts, more preferably 55.7 parts;
1.3～1.9 parts of aspartic acids are preferably 1.5～1.65 parts, more preferably 1.61 parts;
0.8～1.2 part of Threonine is preferably 0.9～1.1 part, more preferably 1 part;
0.45～0.7 part of Serine is preferably 0.55～0.65 part, more preferably 0.6 part;
2～3 parts in L-glutamic acid is preferably 2.3～2.8 parts, more preferably 2.56 parts;
0.8～1.1 part of glycine is preferably 0.85～1.05 part, more preferably 0.96 part;
1.3～1.7 parts of L-Ala are preferably 1.4～1.6 parts, more preferably 1.5 parts;
0.8～1.2 part of α-amino-isovaleric acid is preferably 0.9～1.1 part, more preferably 0.99 part;
0.35～0.55 part of methionine(Met) is preferably 0.4～0.5 part, more preferably 0.44 part;
0.5～0.8 part of Isoleucine is preferably 0.6～0.7 part, more preferably 0.63 part;
1.1～1.6 parts of leucines are preferably 1.25～1.45 parts, more preferably 1.36 parts;
0.55～0.9 part in tyrosine is preferably 0.65～0.8 part, more preferably 0.72 part;
0.5～0.85 part of phenylalanine is preferably 0.6～0.75 part, more preferably 0.67 part;
0.8～1.2 part of Histidine is preferably 0.9～1.1 part, more preferably 1.02 parts; With,
Arginine, is preferably 1.1～1.3 parts, more preferably 1.18 parts by 1～1.5 part;
(3) filtrate that obtains to step (2), add sulfuric acid and concentrate drying to water ratio less than 3% (w/w).
2. method claimed in claim 1, wherein the aminoacid sequence of variant is for adding, lack the aminoacid sequence shown in SEQ ID No:1 or replacing the aminoacid sequence that and several amino-acid residue obtain, the polynucleotide of this variant of optimized encoding import behind the bacterium that produces 1B under fermentation conditions liquid culture, and the supernatant liquor of cultivation comprises the amino acid such as weight proportion as described in the claim l.
3. method claimed in claim 1, wherein the mol ratio of Methionin and sulfuric acid is 1～3: 0.5～1.5, is preferably 1.5～2.5: 0.75～1.25, more preferably 2: 1.
4. method claimed in claim 1, wherein bacterium is intestinal bacteria, preferably to the intestinal bacteria of 1B feedback inhibition desensitization.
5. method claimed in claim 1, wherein filter membrane is that molecular weight cut-off is the filter membrane of 500～5000Da, preferably molecular weight cut-off is the filter membrane of 800～3000Da, is more preferably the filter membrane that molecular weight cut-off is 900～2000Da, most preferably is that molecular weight cut-off is the filter membrane of 1000Da.
6. the product (it is fodder additives preferably) that contains L-lysine sulfate, wherein lysine content is greater than 54% (w/w), be preferably greater than 55% (w/w), also preferred content is 54～60% (w/w), more preferably 55～57% (w/w) most preferably are 55.7% (w/w).
7. product claimed in claim 6, it comprises 72.1～80.1 parts of lysine sulfate, is preferably 73.5～76.1 parts, more preferably 74.4 parts; 1.3～1.9 parts of aspartic acids are preferably 1.5～1.65 parts, more preferably 1.61 parts; With, 2～3 parts in L-glutamic acid is preferably 2.3～2.8 parts, and more preferably 2.56 parts, preferably it comprises:
72.1～80.1 parts of lysine sulfate are preferably 73.5～76.1 parts, more preferably 74.4 parts;
1.3～1.9 parts of aspartic acids are preferably 1.5～1.65 parts, more preferably 1.61 parts;
0.8～1.2 part of Threonine is preferably 0.9～1.1 part, more preferably 1 part;
0.45～0.7 part of Serine is preferably 0.55～0.65 part, more preferably 0.6 part;
2～3 parts in L-glutamic acid is preferably 2.3～2.8 parts, more preferably 2.56 parts;
0.8～1.1 part of glycine is preferably 0.85～1.05 part, more preferably 0.96 part;
1.3～1.7 parts of L-Ala are preferably 1.4～1.6 parts, more preferably 1.5 parts;
0.8～1.2 part of α-amino-isovaleric acid is preferably 0.9～1.1 part, more preferably 0.99 part;
0.35～0.55 part of methionine(Met) is preferably 0.4～0.5 part, more preferably 0.44 part;
0.5～0.8 part of Isoleucine is preferably 0.6～0.7 part, more preferably 0.63 part;
1.1～1.6 parts of leucines are preferably 1.25～1.45 parts, more preferably 1.36 parts;
0.55～0.9 part in tyrosine is preferably 0.65～0.8 part, more preferably 0.72 part;
0.5～0.85 part of phenylalanine is preferably 0.6～0.75 part, more preferably 0.67 part;
0.8～1.2 part of Histidine is preferably 0.9～1.1 part, more preferably 1.02 parts; With,
Arginine, is preferably 1.1～1.3 parts, more preferably 1.18 parts by 1～1.5 part.
8. product claimed in claim 7, its water ratio preferably less than 3% (w/w), is more preferably less than 2.5% (w/w) less than 5% (w/w).
9. product claimed in claim 7, it is by arbitrary described method preparation of claim 1～5.
10. lysine sulfate, aspartic acid and L-glutamic acid are united the application in the arbitrary described product of preparation claim 6～9.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310438880.6A CN103451223B (en) | 2012-11-07 | 2012-11-07 | The method of high-purity lysine sulphate is prepared in disposable fermentation |
| CN 201210440082 CN102925505B (en) | 2012-11-07 | 2012-11-07 | Method for preparing highly-purified L-Lysine sulphate through one-time fermentation |
| CN201310438355.4A CN103805627B (en) | 2012-11-07 | 2012-11-07 | The method that disposable fermentation prepares high-purity lysine sulphate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210440082 CN102925505B (en) | 2012-11-07 | 2012-11-07 | Method for preparing highly-purified L-Lysine sulphate through one-time fermentation |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310438355.4A Division CN103805627B (en) | 2012-11-07 | 2012-11-07 | The method that disposable fermentation prepares high-purity lysine sulphate |
| CN201310438880.6A Division CN103451223B (en) | 2012-11-07 | 2012-11-07 | The method of high-purity lysine sulphate is prepared in disposable fermentation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102925505A true CN102925505A (en) | 2013-02-13 |
| CN102925505B CN102925505B (en) | 2013-11-06 |
Family
ID=47640432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210440082 Active CN102925505B (en) | 2012-11-07 | 2012-11-07 | Method for preparing highly-purified L-Lysine sulphate through one-time fermentation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102925505B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103553951A (en) * | 2013-10-31 | 2014-02-05 | 安徽丰原发酵技术工程研究有限公司 | Method of extracting and preparing lysine sulphate from fermenting liquid containing lysin |
| CN103739508A (en) * | 2014-01-20 | 2014-04-23 | 诸城东晓生物科技有限公司 | Extraction technology of 98.5% lysine hydrochloride |
-
2012
- 2012-11-07 CN CN 201210440082 patent/CN102925505B/en active Active
Non-Patent Citations (4)
| Title |
|---|
| 冯占雨 张建东 谯仕彦: "70%含量预混料专用型赖氨酸硫酸盐物理性状的研究", 《HTTP://WWW.SCAAA.ORG.CN/SHOWINFO.ASPX?NID=342&PID=396&ID=397》 * |
| 冯占雨 等: "70%赖氨酸硫酸盐和98%赖氨酸硫酸盐在饲料中混合均匀度的比较研究", 《动物营养》 * |
| 谯仕彦: "新型氨基酸的应用研究", 《兽药与饲料》 * |
| 邝声耀: "新型赖氨酸应用推广的研究进展", 《四川畜牧兽医》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103553951A (en) * | 2013-10-31 | 2014-02-05 | 安徽丰原发酵技术工程研究有限公司 | Method of extracting and preparing lysine sulphate from fermenting liquid containing lysin |
| CN103553951B (en) * | 2013-10-31 | 2015-07-15 | 安徽丰原发酵技术工程研究有限公司 | Method of extracting and preparing lysine sulphate from fermenting liquid containing lysin |
| CN103739508A (en) * | 2014-01-20 | 2014-04-23 | 诸城东晓生物科技有限公司 | Extraction technology of 98.5% lysine hydrochloride |
| CN103739508B (en) * | 2014-01-20 | 2015-07-15 | 诸城东晓生物科技有限公司 | Extraction technology of 98.5% lysine hydrochloride |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102925505B (en) | 2013-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109247447B (en) | Yeast hydrolysate for replacing plasma protein powder to produce milk replacer and preparation method thereof | |
| CN103555779B (en) | A kind of method of fermentative production γ-aminobutyric acid | |
| CN102524518B (en) | Method for producing antibacterial peptide by using brevibacillus laterosporu | |
| US20050124053A1 (en) | Bacterial hydrolystate | |
| CN104480058A (en) | High yield L-leucine engineering bacterium and application thereof | |
| CN106282242A (en) | Yeast extract containing nucleotide and preparation method thereof and application | |
| CN102925505B (en) | Method for preparing highly-purified L-Lysine sulphate through one-time fermentation | |
| CN104480057A (en) | Construction method and application of L-isoleucine producing genetically engineered bacteria | |
| CN104745650A (en) | Preparation method of combined-state glutamine used for improving nutrients of piglet intestines | |
| Wendisch et al. | Metabolic engineering for valorization of agri-and aqua-culture sidestreams for production of nitrogenous compounds by Corynebacterium glutamicum | |
| CN106148440B (en) | Production of agmatine by fermentation method | |
| CA3193923A1 (en) | Nitrogen-enhanced yeast-based fertilizer | |
| Asad et al. | Production of single cell protein from delignified corn cob by Arachniotus species | |
| CN102911976B (en) | Method for preparing medium-purity lysine sulphate through fermentation | |
| CN102925506B (en) | Method for preparing high purity lysine sulfate through fermenting | |
| CN103013950B (en) | Lipase | |
| CN102277403B (en) | Production technology of yellow wine lees proteins by enzymatic extraction | |
| CN110663813B (en) | Fish meal microbial fermentation and enzymolysis method | |
| CN107312723A (en) | The yeast strain of high yield cAMP a kind of and its application | |
| CN103451223A (en) | High-purity lysine sulfate preparation method based on one-time fermentation | |
| CN103805646B (en) | Fermentation is for the method and products thereof of high purity lysine salt | |
| CN103805627A (en) | Method for preparing high-purity lysine sulfate through once fermentation | |
| CN105603017A (en) | Method for producing trans-4-hydroxyl-L-proline by means of fermentation by aid of recombinant corynebacterium acetoacidophilum | |
| CN103451221A (en) | Method for preparing high-purity L-lysine salt through fermentation and product produced by using method | |
| CN103805626A (en) | Method for preparing lysine salt through fermentation and product thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for preparing highly-purified L-Lysine sulphate through one-time fermentation Effective date of registration: 20190201 Granted publication date: 20131106 Pledgee: Yongning County Branch of China Agricultural Development Bank Pledgor: NINGXIA EPPEN BIOTECH Co.,Ltd.|INNER MONGOLIA EPPEN BIOTECH Co.,Ltd. Registration number: 2019640000001 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200116 Granted publication date: 20131106 Pledgee: Yongning County Branch of China Agricultural Development Bank Pledgor: NINGXIA EPPEN BIOTECH Co.,Ltd. Registration number: 2019640000001 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for preparing highly-purified L-Lysine sulphate through one-time fermentation Effective date of registration: 20200120 Granted publication date: 20131106 Pledgee: Yongning County Branch of China Agricultural Development Bank Pledgor: NINGXIA EPPEN BIOTECH Co.,Ltd. Registration number: Y2020640000002 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210126 Granted publication date: 20131106 Pledgee: Yongning County Branch of China Agricultural Development Bank Pledgor: NINGXIA EPPEN BIOTECH Co.,Ltd. Registration number: Y2020640000002 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of high purity lysine sulfate by one time fermentation Effective date of registration: 20210127 Granted publication date: 20131106 Pledgee: Yongning County Branch of China Agricultural Development Bank Pledgor: NINGXIA EPPEN BIOTECH Co.,Ltd. Registration number: Y2021640000001 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220129 Granted publication date: 20131106 Pledgee: Yongning County Branch of China Agricultural Development Bank Pledgor: NINGXIA EPPEN BIOTECH Co.,Ltd. Registration number: Y2021640000001 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of high purity lysine sulfate by one-time fermentation Effective date of registration: 20220323 Granted publication date: 20131106 Pledgee: Yongning County Branch of China Agricultural Development Bank Pledgor: NINGXIA EPPEN BIOTECH Co.,Ltd. Registration number: Y2022640000002 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230315 Granted publication date: 20131106 Pledgee: Yongning County Branch of China Agricultural Development Bank Pledgor: NINGXIA EPPEN BIOTECH Co.,Ltd.|INNER MONGOLIA EPPEN BIOTECH Co.,Ltd.|Heilongjiang Yipin Biotechnology Co.,Ltd. Registration number: Y2022640000002 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method for preparing high-purity lysine sulfate through one-time fermentation Granted publication date: 20131106 Pledgee: Yongning County Branch of China Agricultural Development Bank Pledgor: NINGXIA EPPEN BIOTECH Co.,Ltd.|INNER MONGOLIA EPPEN BIOTECH Co.,Ltd.|Heilongjiang Yipin Biotechnology Co.,Ltd. Registration number: Y2024640000005 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |